Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202436
Status:
COMPLETED
Last Update Posted:
2009-10-20
First Post:
2005-09-13
Brief Title:
HaemochromatosisPhlebotomy Versus Erythrocytapheresis Therapy
Sponsor:
Sanquin Research Blood Bank Divisions
Organization:
Sanquin Research Blood Bank Divisions
Study Overview
Official Title:
Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy both regarding the impact on the reduction in iron overload as well as reduction in patient burden Aspects of cost effectiveness will be included in the final analysis Results of the study would allow decision-making based on Evidence Based Medicine on the best therapeutic options available for newly-diagnosed as well as existing primary hemochromatosis patients
Detailed Description:
In this project we plan to evaluate the effectiveness of erythrocytapheresis against phlebotomy both regarding the impact on the reduction in iron overload as well as reduction in patient burden Aspects of cost effectiveness will be included in the final analysis The results of the study would allow decision-making based on Evidence Based Medicine on the best therapeutic options available for newly-diagnosed as well as existing primary hemochromatosis patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None